Literature DB >> 2702966

Angina pectoris-like pain provoked by i.v. bolus of adenosine: relationship to coronary sinus blood flow, heart rate and blood pressure in healthy volunteers.

C Sylvén1, B Jonzon, A Edlund.   

Abstract

After finding the maximum tolerated i.v. bolus dose of adenosine, three fractions of this dose were given randomly to five volunteers in a double-blind manner. Pain, estimated by a 10-graded category-ratio scale, ECG and coronary sinus blood flow (CSBF), measured by thermodilution and intra-arterial blood pressure, were continuously recorded. At the highest tolerated dose (10.3 +/- 2.3 mg), the ECG showed short lasting (less than 5 s) AV-block but no ischaemic signs. Following the maximum dose, pain started 15 +/- 2 s after injection, reached a maximum (median 6 of 10 grades) after 25 +/- 4 s and disappeared after 62 +/- 7 s. Basal CSBF was 84 +/- 14 ml/min-1, and increased to 297 +/- 48 ml/min. The rise in CSBF started 2.4 +/- 0.8 s before pain appeared (P less than 0.05), but reached its peak 18 +/- 2 s after maximum pain (P less than 0.005). Although maximum coronary vasodilation was induced at the lowest dose of adenosine given--1/3 of the maximum dose--chest pain increased in a dose-dependent manner. When AV-block did not occur, diastolic pressure did not change from baseline, while systolic blood pressure increased by 5 +/- 2% (ANOVA, P less than 0.0001) and heart rate increased by 40 +/- 7% (ANOVA, P less than 0.0001). Following AV-block, except for a decrease of short duration in heart rate and systolic and diastolic blood pressures, the responses were similar. In conclusion, the vasodilator adenosine given as an i.v. bolus to human volunteers who were awake increased heart rate and systolic blood pressure with unchanged diastolic pressure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702966     DOI: 10.1093/oxfordjournals.eurheartj.a059380

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

1.  Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X).

Authors:  P M Elliott; K Krzyzowska-Dickinson; R Calvino; C Hann; J C Kaski
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

Review 2.  Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.

Authors:  D Faulds; P Chrisp; M M Buckley
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

Review 3.  The therapeutic and diagnostic cardiac electrophysiological uses of adenosine.

Authors:  A D Malcolm; C J Garratt; A J Camm
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

4.  Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms.

Authors:  B Lagerqvist; C Sylvén; A Waldenström
Journal:  Br Heart J       Date:  1992-09

Review 5.  Mechanisms of pain in angina pectoris--a critical review of the adenosine hypothesis.

Authors:  C Sylvén
Journal:  Cardiovasc Drugs Ther       Date:  1993-11       Impact factor: 3.727

6.  In vivo assessment of coronary flow and cardiac function after bolus adenosine injection in adenosine receptor knockout mice.

Authors:  Bunyen Teng; Stephen L Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  Physiol Rep       Date:  2016-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.